SARS-CoV-RBD

SARS-CoV-RBD

Background

This product contains the receptor binding domain (RBD) of the spike glycoprotein protein (S-protein) of the SARS-CoV corona virus (2002). Infection with this virus causes severe acute respiratory syndrome. The spike protein is the common target for neutralizing antibodies and vaccines… Learn more

Production platform: This product has been produced in HEK293 cells using the rPEx™ recombinant protein production platform.